← Back to Screener
BGM Group Ltd. Class A Ordinary Shares (BGM)
Price$0.29
Value ScoreB
Growth ScoreD
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (26W)-107.26%
Price vs S&P 500 (4W)10.10%
VGM Score37.28
Market Capitalization$53.53M
All Metrics
P/CF (Annual)98.36x
Book Value / Share (Quarterly)$1.85
P/TBV (Annual)1.01x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-23.97%
Cash Flow / Share (Quarterly)$-0.07
Price vs S&P 500 (YTD)-102.21%
Gross Margin (TTM)19.41%
Net Profit Margin (TTM)-10.13%
EPS (TTM)$-0.28
10-Day Avg Trading Volume0.23M
EPS Excl Extra (TTM)$-0.28
Revenue Growth (5Y)-11.45%
EPS (Annual)$-0.20
ROI (Annual)-3.38%
Gross Margin (Annual)16.39%
Net Profit Margin (5Y Avg)-1.04%
Cash / Share (Quarterly)$0.15
Revenue Growth QoQ (YoY)13.92%
ROA (Last FY)-2.72%
Revenue Growth TTM (YoY)-10.12%
EBITD / Share (TTM)$-0.05
ROE (5Y Avg)1.12%
Operating Margin (TTM)-7.91%
Cash Flow / Share (Annual)$-0.13
P/B Ratio0.29x
P/B Ratio (Quarterly)6.11x
Net Income / Employee (Annual)$-4,500
Net Interest Coverage (TTM)-0.28x
ROA (TTM)-2.09%
EPS Incl Extra (Annual)$-0.20
Current Ratio (Annual)3.39x
Quick Ratio (Quarterly)1.33x
3-Month Avg Trading Volume0.28M
52-Week Price Return-97.60%
Revenue / Employee (TTM)$83,100
Tangible BV / Share (Quarterly)$1.81
P/S Ratio (Annual)2.13x
Asset Turnover (Annual)0.47x
52-Week High$17.17
Operating Margin (5Y Avg)1.83%
EPS Excl Extra (Annual)$-0.20
CapEx CAGR (5Y)16.29%
26-Week Price Return-95.87%
Quick Ratio (Annual)2.73x
13-Week Price Return-70.45%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)1.82x
Enterprise Value$45.48M
Revenue / Share Growth (5Y)21.40%
Asset Turnover (TTM)0.21x
Revenue / Employee (Annual)$77,700
Inventory Turnover (Annual)4.18x
Pretax Margin (Annual)-8.52%
Cash / Share (Annual)$3.02
3-Month Return Std Dev146.12%
Gross Margin (5Y Avg)10.94%
Net Income / Employee (TTM)$-8,400
EBITDA CAGR (5Y)-38.03%
ROE (Last FY)-3.38%
Net Interest Coverage (Annual)-0.22x
EPS Basic Excl Extra (Annual)$-0.20
P/FCF (TTM)19.60x
Receivables Turnover (TTM)8.60x
Total Debt / Equity (Quarterly)0.01x
EPS Incl Extra (TTM)$-0.28
Receivables Turnover (Annual)14.26x
ROI (TTM)-2.40%
P/S Ratio (TTM)1.99x
Pretax Margin (5Y Avg)-1.13%
Revenue / Share (Annual)$3.47
Tangible BV / Share (Annual)$6.36
Price vs S&P 500 (52W)-124.64%
Year-to-Date Return-91.19%
5-Day Price Return2.49%
EPS Normalized (Annual)$-0.20
ROA (5Y Avg)-0.31%
Net Profit Margin (Annual)-5.75%
Month-to-Date Return2.49%
EBITD / Share (Annual)$0.09
Operating Margin (Annual)-2.25%
ROI (5Y Avg)0.15%
EPS Basic Excl Extra (TTM)$-0.28
P/TBV (Quarterly)6.26x
P/B Ratio (Annual)0.90x
Inventory Turnover (TTM)3.21x
Pretax Margin (TTM)-28.31%
Book Value / Share (Annual)$7.12
Price vs S&P 500 (13W)-80.95%
Beta1.80x
P/FCF (Annual)5.70x
Revenue / Share (TTM)$0.85
ROE (TTM)-2.42%
52-Week Low$0.26
vGradeB
gGradeD
mGradeF
vgmGradeD
Show chart for
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
BGMBGM Group Ltd. Class A Ordinary Shares | B | D | F | $0.29 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
BGM Group Ltd manufactures pharmaceutical active ingredients and medical products through biopharmaceutical and bio-extraction operations. Its core revenue comes from oxytetracycline APIs, licorice preparations, and traditional Chinese medicine derivatives (TCMD), with secondary contributions from crude heparin sodium and specialty sausage casings. The company specializes in producing essential pharmaceutical intermediates for the healthcare industry.